BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 818993 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCc1ccccc1 InChI=1S/C26H25NO4/c28-25(24(20-12-6-2-7-13-20)21-14-8-3-9-15-21)27-17-22(16-23(27)26(29)30)31-18-19-10-4-1-5-11-19/h1-15,22-24H,16-18H2,(H,29,30)/t22-,23-/m0/s1 BFTWTVUNMXYGBN-GOTSBHOMSA-N 318742 (2S,4S)-4-(benzyloxy)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 2::US9624243, 2 Type-2 angiotensin II receptor Human 114 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318742&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677468 384222031 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 818994 OC(=O)[C@@H]1C[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCc1ccccc1 InChI=1S/C26H25NO4/c28-25(24(20-12-6-2-7-13-20)21-14-8-3-9-15-21)27-17-22(16-23(27)26(29)30)31-18-19-10-4-1-5-11-19/h1-15,22-24H,16-18H2,(H,29,30)/t22-,23+/m1/s1 BFTWTVUNMXYGBN-PKTZIBPZSA-N 318743 (2S,4R)-4-(benzyloxy)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 3::US9624243, 3 Type-2 angiotensin II receptor Human 193 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318743&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677779 384222032 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 818995 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCC=Cc1ccccc1 InChI=1S/C28H27NO4/c30-27(26(22-14-6-2-7-15-22)23-16-8-3-9-17-23)29-20-24(19-25(29)28(31)32)33-18-10-13-21-11-4-1-5-12-21/h1-17,24-26H,18-20H2,(H,31,32)/b13-10+/t24-,25-/m0/s1 XDYXKVYDCSLVKA-KYKXIQHDSA-N 318744 (2S,4S)-4-cinnamyloxy-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 5::US9624243, 5 Type-2 angiotensin II receptor Human 90.0 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318744&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681564 384222033 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 818996 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C28H29NO4/c30-27(26(22-14-6-2-7-15-22)23-16-8-3-9-17-23)29-20-24(19-25(29)28(31)32)33-18-10-13-21-11-4-1-5-12-21/h1-9,11-12,14-17,24-26H,10,13,18-20H2,(H,31,32)/t24-,25-/m0/s1 OSURWJVNFXMFKH-DQEYMECFSA-N 318745 Compound 9 (2S,4R)-1-(2,2-diphenylacetyl)-4-(3-phenylpropoxy)pyrrolidine-2-carboxylic acid::US10370388, Compound 6::US9624243, 6 Type-2 angiotensin II receptor Human 181 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318745&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71604416 384222034 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 818997 OC(=O)[C@@H]1C[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C28H29NO4/c30-27(26(22-14-6-2-7-15-22)23-16-8-3-9-17-23)29-20-24(19-25(29)28(31)32)33-18-10-13-21-11-4-1-5-12-21/h1-9,11-12,14-17,24-26H,10,13,18-20H2,(H,31,32)/t24-,25+/m1/s1 OSURWJVNFXMFKH-RPBOFIJWSA-N 318746 (2S,4R)-1-(2,2-diphenylacetyl)-4-(3-phenylpropoxy)pyrrolidine-2-carboxylic acid::US10370388, Compound 9::US9624243, 9 Type-2 angiotensin II receptor Human 98.6 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318746&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681480 384222035 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 818998 OC(=O)C1Cc2c(cccc2OCc2ccccc2)N1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C30H25NO4/c32-29(28(22-13-6-2-7-14-22)23-15-8-3-9-16-23)31-25-17-10-18-27(24(25)19-26(31)30(33)34)35-20-21-11-4-1-5-12-21/h1-18,26,28H,19-20H2,(H,33,34) VPSJEEFGRNBADP-UHFFFAOYSA-N 410208 US10370388, Compound 15 Type-2 angiotensin II receptor Human 54.5 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410208&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677746 406791773 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 818999 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OC[C@@H]1C[C@H]1c1ccccc1 InChI=1S/C29H29NO4/c31-28(27(21-12-6-2-7-13-21)22-14-8-3-9-15-22)30-18-24(17-26(30)29(32)33)34-19-23-16-25(23)20-10-4-1-5-11-20/h1-15,23-27H,16-19H2,(H,32,33)/t23-,24-,25-,26-/m0/s1 CYMXHUCDSZNIGX-CQJMVLFOSA-N 318748 (2S,4S)-1-(2,2-diphenylacetyl)-4-(((1R,2R)-2-phenylcyclopropyl)methoxy)pyrrolidine-2-carboxylic ::US10370388, Compound 16::US9624243, 16 Type-2 angiotensin II receptor Human 6654 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318748&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117776871 384222037 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819000 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OC[C@@H]1C[C@@H]1c1ccccc1 InChI=1S/C29H29NO4/c31-28(27(21-12-6-2-7-13-21)22-14-8-3-9-15-22)30-18-24(17-26(30)29(32)33)34-19-23-16-25(23)20-10-4-1-5-11-20/h1-15,23-27H,16-19H2,(H,32,33)/t23-,24-,25+,26-/m0/s1 CYMXHUCDSZNIGX-SSUZURRFSA-N 318749 (2S,4S)-1-(2,2-diphenylacetyl)-4-(((1R,2S)-2-phenylcyclopropyl)methoxy)pyrrolidine-2-carboxylic acid ::US10370388, Compound 17::US9624243, 17 Type-2 angiotensin II receptor Human 3974 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318749&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681518 384222038 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819001 CN(CCCc1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C29H32N2O3/c1-30(19-11-14-22-12-5-2-6-13-22)25-20-26(29(33)34)31(21-25)28(32)27(23-15-7-3-8-16-23)24-17-9-4-10-18-24/h2-10,12-13,15-18,25-27H,11,14,19-21H2,1H3,(H,33,34)/t25-,26-/m0/s1 IODJNDRBUIMETF-UIOOFZCWSA-N 318750 (2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl(3-phenylpropyl)amino)pyrrolidine-2-carboxylic acid::US10370388, Compound 21::US9624243, 21 Type-2 angiotensin II receptor Human 62.1 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318750&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677556 384222039 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819002 CN(CCc1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C28H30N2O3/c1-29(18-17-21-11-5-2-6-12-21)24-19-25(28(32)33)30(20-24)27(31)26(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-26H,17-20H2,1H3,(H,32,33)/t24-,25-/m0/s1 QPRNQNJCPFYMHW-DQEYMECFSA-N 318751 (2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl(phenylethylamino)pyrrolidine-2-carboxylic acid::US10370388, Compound 22::US9624243, 22 Type-2 angiotensin II receptor Human 384 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318751&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681622 384222040 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819003 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCN(CC1)c1ccccc1 InChI=1S/C29H31N3O3/c33-28(27(22-10-4-1-5-11-22)23-12-6-2-7-13-23)32-21-25(20-26(32)29(34)35)31-18-16-30(17-19-31)24-14-8-3-9-15-24/h1-15,25-27H,16-21H2,(H,34,35)/t25-,26-/m0/s1 XYLRMVKCCBZNNZ-UIOOFZCWSA-N 410214 US10370388, Compound 23 Type-2 angiotensin II receptor Human 290 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410214&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762822 406791779 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819004 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCOC[C@@H]1Cc1ccccc1 InChI=1S/C30H32N2O4/c33-29(28(23-12-6-2-7-13-23)24-14-8-3-9-15-24)32-20-25(19-27(32)30(34)35)31-16-17-36-21-26(31)18-22-10-4-1-5-11-22/h1-15,25-28H,16-21H2,(H,34,35)/t25-,26-,27-/m0/s1 TVDXVKSOROZAFV-QKDODKLFSA-N 318753 (2S,4S)-4-((S)-3-benzylmorpholino)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 28::US9624243, 28 Type-2 angiotensin II receptor Human 86.9 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318753&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681525 384222042 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819005 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)Oc1ccccc1Oc1ccccc1 InChI=1S/C31H27NO5/c33-30(29(22-12-4-1-5-13-22)23-14-6-2-7-15-23)32-21-25(20-26(32)31(34)35)37-28-19-11-10-18-27(28)36-24-16-8-3-9-17-24/h1-19,25-26,29H,20-21H2,(H,34,35)/t25-,26-/m0/s1 JOXFWLBKXCVJIC-UIOOFZCWSA-N 410216 US10370388, Compound 35 Type-2 angiotensin II receptor Human 540 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410216&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681581 406791781 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819006 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCC#Cc1ccccc1 InChI=1S/C28H25NO4/c30-27(26(22-14-6-2-7-15-22)23-16-8-3-9-17-23)29-20-24(19-25(29)28(31)32)33-18-10-13-21-11-4-1-5-12-21/h1-9,11-12,14-17,24-26H,18-20H2,(H,31,32)/t24-,25-/m0/s1 XLCYEGBVGLDHQI-DQEYMECFSA-N 410217 US10370388, Compound 36 Type-2 angiotensin II receptor Human 1664 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410217 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410217&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677797 406791782 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819007 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)NCCc1ccccc1 InChI=1S/C27H28N2O3/c30-26(25(21-12-6-2-7-13-21)22-14-8-3-9-15-22)29-19-23(18-24(29)27(31)32)28-17-16-20-10-4-1-5-11-20/h1-15,23-25,28H,16-19H2,(H,31,32)/t23-,24-/m0/s1 VMLXSXJSLHISBZ-ZEQRLZLVSA-N 318756 (2S,4S)-1-(2,2-diphenylacetyl)-4-(phenethylamino)-pyrrolidine-2-carboxylic acid::US10370388, Compound 46::US9624243, 46 Type-2 angiotensin II receptor Human 2257 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318756&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677614 384222045 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819008 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC[C@H](C1)c1ccccc1 InChI=1S/C30H32N2O3/c33-29(28(23-13-6-2-7-14-23)24-15-8-3-9-16-24)32-21-26(19-27(32)30(34)35)31-18-10-17-25(20-31)22-11-4-1-5-12-22/h1-9,11-16,25-28H,10,17-21H2,(H,34,35)/t25-,26+,27+/m1/s1 NLEUYIKWYGKLNG-PVHODMMVSA-N 410219 US10370388, Compound 48 Type-2 angiotensin II receptor Human 89.4 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410219&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677790 406791784 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819009 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC[C@@H](C1)c1ccccc1 InChI=1S/C30H32N2O3/c33-29(28(23-13-6-2-7-14-23)24-15-8-3-9-16-24)32-21-26(19-27(32)30(34)35)31-18-10-17-25(20-31)22-11-4-1-5-12-22/h1-9,11-16,25-28H,10,17-21H2,(H,34,35)/t25-,26-,27-/m0/s1 NLEUYIKWYGKLNG-QKDODKLFSA-N 318758 (2S,4S)-1-(2,2-diphenylacetyl)-4-((R)-3-phenylpiperidin-1-yl)pyrrolidine-2-carboxylic acid::US10370388, Compound 49::US9624243, 49 Type-2 angiotensin II receptor Human 58.8 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318758&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762386 384222047 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819010 OC(=O)[C@H]1C[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC[C@@H](C1)c1ccccc1 InChI=1S/C30H32N2O3/c33-29(28(23-13-6-2-7-14-23)24-15-8-3-9-16-24)32-21-26(19-27(32)30(34)35)31-18-10-17-25(20-31)22-11-4-1-5-12-22/h1-9,11-16,25-28H,10,17-21H2,(H,34,35)/t25-,26+,27+/m0/s1 NLEUYIKWYGKLNG-OYUWMTPXSA-N 318760 US10370388, Compound 50::US9624243, 51 Type-2 angiotensin II receptor Human 67.3 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318760&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374611 384222049 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819011 OC(=O)[C@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC[C@@H](C1)c1ccccc1 InChI=1S/C30H32N2O3/c33-29(28(23-13-6-2-7-14-23)24-15-8-3-9-16-24)32-21-26(19-27(32)30(34)35)31-18-10-17-25(20-31)22-11-4-1-5-12-22/h1-9,11-16,25-28H,10,17-21H2,(H,34,35)/t25-,26-,27+/m0/s1 NLEUYIKWYGKLNG-GMQQYTKMSA-N 410222 US10370388, Compound 51 Type-2 angiotensin II receptor Human 50.3 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410222&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 146676241 406791786 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819012 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCCC(Cc2ccccc2)C1 InChI=1S/C31H34N2O3/c34-30(29(25-14-6-2-7-15-25)26-16-8-3-9-17-26)33-22-27(20-28(33)31(35)36)32-18-10-13-24(21-32)19-23-11-4-1-5-12-23/h1-9,11-12,14-17,24,27-29H,10,13,18-22H2,(H,35,36)/t24?,27-,28-/m0/s1 ONGGULVSDDXGNW-ACFUZCEKSA-N 318761 (2S,4S)-4-(3-benzylpiperidin-1-yl)-1-(2,2-diphenylacetyl)-pyrrolidine-2-carboxylic acid::US10370388, Compound 53::US9624243, 53 Type-2 angiotensin II receptor Human 43.9 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318761&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677777 384222050 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819013 OC(=O)[C@@H]1C[C@H](COCc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C27H27NO4/c29-26(25(22-12-6-2-7-13-22)23-14-8-3-9-15-23)28-17-21(16-24(28)27(30)31)19-32-18-20-10-4-1-5-11-20/h1-15,21,24-25H,16-19H2,(H,30,31)/t21-,24-/m0/s1 NANMRBILNJFRFQ-URXFXBBRSA-N 410224 US10370388, Compound 54 Type-2 angiotensin II receptor Human 155 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410224&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117788414 406791788 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819014 OC(=O)[C@@H]1C[C@H](CCOCc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C28H29NO4/c30-27(26(23-12-6-2-7-13-23)24-14-8-3-9-15-24)29-19-22(18-25(29)28(31)32)16-17-33-20-21-10-4-1-5-11-21/h1-15,22,25-26H,16-20H2,(H,31,32)/t22-,25-/m0/s1 HOCFJOJMTFGJRJ-DHLKQENFSA-N 318763 (2S,4R)-4-(2-(benzyloxy)ethyl)-1-(2,2-diphenylacetyl)-pyrrolidine-2-carboxylic acid::US10370388, Compound 55::US9624243, 55 Type-2 angiotensin II receptor Human 386 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318763&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677689 384222052 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819015 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)c1ncc(o1)-c1ccccc1 InChI=1S/C28H24N2O4/c31-27(25(20-12-6-2-7-13-20)21-14-8-3-9-15-21)30-18-22(16-23(30)28(32)33)26-29-17-24(34-26)19-10-4-1-5-11-19/h1-15,17,22-23,25H,16,18H2,(H,32,33)/t22-,23-/m0/s1 NXSLHNQRFXQMPE-GOTSBHOMSA-N 410226 US10370388, Compound 56 Type-2 angiotensin II receptor Human 316 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410226&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677724 406791790 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819016 OC(=O)[C@@H]1C[C@H](CS(=O)(=O)CCc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C28H29NO5S/c30-27(26(23-12-6-2-7-13-23)24-14-8-3-9-15-24)29-19-22(18-25(29)28(31)32)20-35(33,34)17-16-21-10-4-1-5-11-21/h1-15,22,25-26H,16-20H2,(H,31,32)/t22-,25-/m0/s1 MDMRDTVRNZPFDL-DHLKQENFSA-N 410227 US10370388, Compound 58 Type-2 angiotensin II receptor Human 3050 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410227&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622328 406791791 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819017 OC(=O)[C@@H]1CC(CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCCC1Cc1ccccc1 InChI=1S/C30H32N2O3/c33-29(28(23-13-6-2-7-14-23)24-15-8-3-9-16-24)32-21-26(20-27(32)30(34)35)31-18-10-17-25(31)19-22-11-4-1-5-12-22/h1-9,11-16,25-28H,10,17-21H2,(H,34,35)/t25?,26?,27-/m0/s1 QBODAMCFFCQGDX-RCSZBHJWSA-N 410229 US10370388, Compound 61-A::US10370388, Compound 61-B Type-2 angiotensin II receptor Human 83.3 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410229&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 146676242 406791793 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819018 OC(=O)[C@@H]1CC(CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCCC1Cc1ccccc1 InChI=1S/C30H32N2O3/c33-29(28(23-13-6-2-7-14-23)24-15-8-3-9-16-24)32-21-26(20-27(32)30(34)35)31-18-10-17-25(31)19-22-11-4-1-5-12-22/h1-9,11-16,25-28H,10,17-21H2,(H,34,35)/t25?,26?,27-/m0/s1 QBODAMCFFCQGDX-RCSZBHJWSA-N 410229 US10370388, Compound 61-A::US10370388, Compound 61-B Type-2 angiotensin II receptor Human 107 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410229&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 146676242 406791793 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819019 CN(CCCc1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(C1CCCCC1)c1ccccc1)C(O)=O InChI=1S/C29H38N2O3/c1-30(19-11-14-22-12-5-2-6-13-22)25-20-26(29(33)34)31(21-25)28(32)27(23-15-7-3-8-16-23)24-17-9-4-10-18-24/h2-3,5-8,12-13,15-16,24-27H,4,9-11,14,17-21H2,1H3,(H,33,34)/t25-,26-,27?/m0/s1 BAXNDSAXEQPGMO-TXIPYEPDSA-N 318768 (2S,4S)-1-(2-cyclohexyl-2-phenylacetyl)-4-(methyl(3-phenylpropyl)amino)pyrrolidine-2-carboxylic acid::US10370388, Compound 62::US9624243, 62 Type-2 angiotensin II receptor Human 540 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318768&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681553 384222057 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819020 CN(CC1CC1c1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C30H32N2O3/c1-31(19-24-17-26(24)21-11-5-2-6-12-21)25-18-27(30(34)35)32(20-25)29(33)28(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-28H,17-20H2,1H3,(H,34,35)/t24?,25-,26?,27-/m0/s1 JKDRZXQFDUPUTM-QGCKTULWSA-N 318769 (2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl((2-phenylcyclopropyl)methyl)amino)pyrrolidine-2-carboxylic acid::US10370388, Compound 63::US9624243, 63 Type-2 angiotensin II receptor Human 483 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318769&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762404 384222058 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819021 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)NC(=O)CC(c1ccccc1)c1ccccc1 InChI=1S/C34H32N2O4/c37-31(22-29(24-13-5-1-6-14-24)25-15-7-2-8-16-25)35-28-21-30(34(39)40)36(23-28)33(38)32(26-17-9-3-10-18-26)27-19-11-4-12-20-27/h1-20,28-30,32H,21-23H2,(H,35,37)(H,39,40)/t28-,30-/m0/s1 DEGYKHHABRCMGA-JDXGNMNLSA-N 410233 US10370388, Compound 64 Type-2 angiotensin II receptor Human 3358 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410233&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 146676243 406791796 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819022 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC2(CNC(=O)C2c2ccccc2)CC1 InChI=1S/C33H35N3O4/c37-30-29(25-14-8-3-9-15-25)33(22-34-30)16-18-35(19-17-33)26-20-27(32(39)40)36(21-26)31(38)28(23-10-4-1-5-11-23)24-12-6-2-7-13-24/h1-15,26-29H,16-22H2,(H,34,37)(H,39,40)/t26-,27-,29?/m0/s1 CCKVWWYAVWGVAZ-DARYULOESA-N 318771 (2S,4S)-1-(2,2-diphenylacetyl)-4-(3-oxo-4-phenyl-2,8-diazaspiro[4,5]decan-8-yl)pyrrolidine-2-carboxylic acid::US10370388, Compound 65::US9624243, 65 Type-2 angiotensin II receptor Human 1605 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318771&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117763309 384222060 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819023 CN(CCCc1ccccc1)[C@@H]1CN(C[C@H]1C(O)=O)C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C29H32N2O3/c1-30(19-11-14-22-12-5-2-6-13-22)26-21-31(20-25(26)29(33)34)28(32)27(23-15-7-3-8-16-23)24-17-9-4-10-18-24/h2-10,12-13,15-18,25-27H,11,14,19-21H2,1H3,(H,33,34)/t25-,26-/m1/s1 BSDYLUQKLPPVEB-CLJLJLNGSA-N 318772 (3R,4S)-1-(2,2-diphenylacetyl)-4-(methyl(3-phenylpropyl)amino)pyrrolidine-3-carboxylic acid::US10370388, Compound 67::US9624243, 67 Type-2 angiotensin II receptor Human 3665 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318772&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117761783 384222061 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819024 OC(=O)[C@H]1C[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCCCC1Cc1ccccc1 InChI=1S/C31H34N2O3/c34-30(29(24-14-6-2-7-15-24)25-16-8-3-9-17-25)33-22-27(21-28(33)31(35)36)32-19-11-10-18-26(32)20-23-12-4-1-5-13-23/h1-9,12-17,26-29H,10-11,18-22H2,(H,35,36)/t26?,27-,28-/m1/s1 GMIXLHJQCQOBDJ-DXISBFFWSA-N 318774 (2R,4R)-4-(2-benzylpiperidin-1-yl)-1-(2,2-diphenylacetyl)-pyrrolidine-2-carboxylic acid::US10370388, Compound 70-B::US9624243, 70-A Type-2 angiotensin II receptor Human 1340 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318774&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374615 384222063 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819025 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCCCC1Cc1ccccc1 InChI=1S/C31H34N2O3/c34-30(29(24-14-6-2-7-15-24)25-16-8-3-9-17-25)33-22-27(21-28(33)31(35)36)32-19-11-10-18-26(32)20-23-12-4-1-5-13-23/h1-9,12-17,26-29H,10-11,18-22H2,(H,35,36)/t26?,27-,28-/m0/s1 GMIXLHJQCQOBDJ-UWDVWBIHSA-N 318773 (2S,4S)-4-(2-benzylpiperidin-1-yl)-1-(2,2-diphenylacetyl)-pyrrolidine-2-carboxylic acid::US10370388, Compound 70-A::US9624243, 70-B Type-2 angiotensin II receptor Human 49.1 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318773&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681537 384222062 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819026 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC2(CC1)C(NC2=O)c1ccccc1 InChI=1S/C32H33N3O4/c36-29(27(22-10-4-1-5-11-22)23-12-6-2-7-13-23)35-21-25(20-26(35)30(37)38)34-18-16-32(17-19-34)28(33-31(32)39)24-14-8-3-9-15-24/h1-15,25-28H,16-21H2,(H,33,39)(H,37,38)/t25-,26-,28?/m0/s1 DFXQPZOFUMNKEM-QIELNMHASA-N 318775 (2S,4S)-1-(2,2-diphenylacetyl)-4-(1-oxo-3-phenyl-2,7-diazaspiro[3,5]nonan-7-yl)pyrrolidine-2-carboxylic acid::US10370388, Compound 75::US9624243, 75 Type-2 angiotensin II receptor Human 3829 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318775&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681593 384222064 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819027 OC(=O)[C@H]1C[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C28H29NO4/c30-27(26(22-14-6-2-7-15-22)23-16-8-3-9-17-23)29-20-24(19-25(29)28(31)32)33-18-10-13-21-11-4-1-5-12-21/h1-9,11-12,14-17,24-26H,10,13,18-20H2,(H,31,32)/t24-,25-/m1/s1 OSURWJVNFXMFKH-JWQCQUIFSA-N 410239 US10370388, Compound 76 Type-2 angiotensin II receptor Human 3604 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410239&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681596 406791800 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819028 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC[C@H]2CN(Cc3ccccc3)C[C@@H]12 InChI=1S/C33H37N3O3/c37-32(31(25-13-6-2-7-14-25)26-15-8-3-9-16-26)36-22-28(19-29(36)33(38)39)35-18-10-17-27-21-34(23-30(27)35)20-24-11-4-1-5-12-24/h1-9,11-16,27-31H,10,17-23H2,(H,38,39)/t27-,28-,29-,30+/m0/s1 UUJPTIFRRDNDEN-GCXHJFECSA-N 410240 US10370388, Compound 84 Type-2 angiotensin II receptor Human 75.8 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410240&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89679767 406791801 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819029 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC[C@@H]2CN(Cc3ccccc3)C[C@H]12 InChI=1S/C33H37N3O3/c37-32(31(25-13-6-2-7-14-25)26-15-8-3-9-16-26)36-22-28(19-29(36)33(38)39)35-18-10-17-27-21-34(23-30(27)35)20-24-11-4-1-5-12-24/h1-9,11-16,27-31H,10,17-23H2,(H,38,39)/t27-,28+,29+,30+/m1/s1 UUJPTIFRRDNDEN-RYTSNQFKSA-N 410243 US10370388, Compound 85 Type-2 angiotensin II receptor Human 103 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410243&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117788426 406791804 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819030 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CC[C@H](C1)c1ccccc1 InChI=1S/C29H30N2O3/c32-28(27(22-12-6-2-7-13-22)23-14-8-3-9-15-23)31-20-25(18-26(31)29(33)34)30-17-16-24(19-30)21-10-4-1-5-11-21/h1-15,24-27H,16-20H2,(H,33,34)/t24-,25+,26+/m1/s1 CYQCDNHNWKBGCE-ZNZIZOMTSA-N 410245 US10370388, Compound 86 Type-2 angiotensin II receptor Human 817 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410245&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681625 406791805 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819031 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CC[C@@H](C1)c1ccccc1 InChI=1S/C29H30N2O3/c32-28(27(22-12-6-2-7-13-22)23-14-8-3-9-15-23)31-20-25(18-26(31)29(33)34)30-17-16-24(19-30)21-10-4-1-5-11-21/h1-15,24-27H,16-20H2,(H,33,34)/t24-,25-,26-/m0/s1 CYQCDNHNWKBGCE-GSDHBNRESA-N 410246 US10370388, Compound 87 Type-2 angiotensin II receptor Human 43.6 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410246&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117788427 406791806 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819032 CN(CCCCc1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C30H34N2O3/c1-31(20-12-11-15-23-13-5-2-6-14-23)26-21-27(30(34)35)32(22-26)29(33)28(24-16-7-3-8-17-24)25-18-9-4-10-19-25/h2-10,13-14,16-19,26-28H,11-12,15,20-22H2,1H3,(H,34,35)/t26-,27-/m0/s1 BFGDVADCTRJNRK-SVBPBHIXSA-N 318781 (2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl(4-phenylbutyl)-amino)pyrrolidine-2-carboxylic acid::US10370388, Compound 90::US9624243, 90 Type-2 angiotensin II receptor Human 64.2 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318781&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681591 384222070 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819033 CN(CCCc1ccc(F)cc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C29H31FN2O3/c1-31(18-8-9-21-14-16-24(30)17-15-21)25-19-26(29(34)35)32(20-25)28(33)27(22-10-4-2-5-11-22)23-12-6-3-7-13-23/h2-7,10-17,25-27H,8-9,18-20H2,1H3,(H,34,35)/t25-,26-/m0/s1 KMGJCWPNNFAXPR-UIOOFZCWSA-N 318782 (2S,4S)-1-(2,2-diphenylacetyl)-4-((3-(4-fluorophenyl)-propyl)(methyl)amino)pyrrolidine-2-carboxylic acid::US10370388, Compound 91::US9624243, 91 Type-2 angiotensin II receptor Human 12.0 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318782&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677805 384222071 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819034 COc1ccc(CCCN(C)[C@H]2C[C@H](N(C2)C(=O)C(c2ccccc2)c2ccccc2)C(O)=O)cc1C InChI=1S/C31H36N2O4/c1-22-19-23(16-17-28(22)37-3)11-10-18-32(2)26-20-27(31(35)36)33(21-26)30(34)29(24-12-6-4-7-13-24)25-14-8-5-9-15-25/h4-9,12-17,19,26-27,29H,10-11,18,20-21H2,1-3H3,(H,35,36)/t26-,27-/m0/s1 LLQSSPNKGGGVDA-SVBPBHIXSA-N 318783 (2S,4S)-1-(2,2-diphenylacetyl)-4-((3-(4-methoxy-3-methylphenyl)propyl)(methyl)amino)pyrrolidine-2-carboxylic acid::US10370388, Compound 92::US9624243, 92 Type-2 angiotensin II receptor Human 134 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318783&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681600 384222072 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819035 CC(CCN[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O)c1cccnc1 InChI=1S/C28H31N3O3/c1-20(23-13-8-15-29-18-23)14-16-30-24-17-25(28(33)34)31(19-24)27(32)26(21-9-4-2-5-10-21)22-11-6-3-7-12-22/h2-13,15,18,20,24-26,30H,14,16-17,19H2,1H3,(H,33,34)/t20?,24-,25-/m0/s1 FHWGVVZIYMGQNR-PTOFZMKOSA-N 318784 (2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl(3-pyridinyl)-propyl)amino)pyrrolidine-2-carboxylic acid::US10370388, Compound 93::US9624243, 93 Type-2 angiotensin II receptor Human 126 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318784&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374620 384222073 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819036 OC(=O)[C@@H]1C[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCC=Cc1ccccc1 InChI=1S/C28H27NO4/c30-27(26(22-14-6-2-7-15-22)23-16-8-3-9-17-23)29-20-24(19-25(29)28(31)32)33-18-10-13-21-11-4-1-5-12-21/h1-17,24-26H,18-20H2,(H,31,32)/b13-10+/t24-,25+/m1/s1 XDYXKVYDCSLVKA-BTNBYDJRSA-N 318785 (2S,4R)-4-(cinnamyloxy)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 8::US9624243, 8 Type-2 angiotensin II receptor Human 512 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318785&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374621 384222074 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819037 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)NC(=O)CCc1ccccc1 InChI=1S/C28H28N2O4/c31-25(17-16-20-10-4-1-5-11-20)29-23-18-24(28(33)34)30(19-23)27(32)26(21-12-6-2-7-13-21)22-14-8-3-9-15-22/h1-15,23-24,26H,16-19H2,(H,29,31)(H,33,34)/t23-,24-/m0/s1 MOWSLAHDBCUMSN-ZEQRLZLVSA-N 318754 Compound 96 (2S,4S)-1-(2,2-diphenylacetyl)-4-(3-phenylpropanamido)-pyrrolidine-2-carboxylic acid::US10370388, Compound 96::US9624243, 35 Type-2 angiotensin II receptor Human 2248 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318754&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681631 384222043 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819038 CN([C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O)C(=O)CCc1ccccc1 InChI=1S/C29H30N2O4/c1-30(26(32)18-17-21-11-5-2-6-12-21)24-19-25(29(34)35)31(20-24)28(33)27(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-25,27H,17-20H2,1H3,(H,34,35)/t24-,25-/m0/s1 YAHHFSHBEGPKKO-DQEYMECFSA-N 318787 (2S,4S)-1-(2,2-diphenylacetyl)-4-(N-methyl-3-phenylpropanamido)pyrrolidine-2-carboxylic acid::US10370388, Compound 97::US9624243, 97 Type-2 angiotensin II receptor Human 458 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318787&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762654 384222076 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819039 CC(=O)N(CCCc1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C30H32N2O4/c1-22(33)31(19-11-14-23-12-5-2-6-13-23)26-20-27(30(35)36)32(21-26)29(34)28(24-15-7-3-8-16-24)25-17-9-4-10-18-25/h2-10,12-13,15-18,26-28H,11,14,19-21H2,1H3,(H,35,36)/t26-,27-/m0/s1 UCMHKXKUZOWWNT-SVBPBHIXSA-N 318788 (2S,4S)-1-(2,2-diphenylacetyl)-4-(N-3-phenylpropyl)-acetamido)pyrrolidine-2-carboxylic acid::US10370388, Compound 98::US9624243, 98 Type-2 angiotensin II receptor Human 240 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318788&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681498 384222077 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819040 CS(=O)(=O)N(CCCc1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C29H32N2O5S/c1-37(35,36)31(19-11-14-22-12-5-2-6-13-22)25-20-26(29(33)34)30(21-25)28(32)27(23-15-7-3-8-16-23)24-17-9-4-10-18-24/h2-10,12-13,15-18,25-27H,11,14,19-21H2,1H3,(H,33,34)/t25-,26-/m0/s1 IMTGAFVXLONOEN-UIOOFZCWSA-N 318789 (2S,4S)-1-(2,2-diphenylacetyl)-4-(N-(3-phenylpropyl)-methylsulfonamido)pyrrolidine-2-carboxylic acid::US10370388, Compound 99::US9624243, 99 Type-2 angiotensin II receptor Human 536 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318789&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677117 384222078 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819041 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)n1nncc1-c1ccccc1 InChI=1S/C27H24N4O3/c32-26(25(20-12-6-2-7-13-20)21-14-8-3-9-15-21)30-18-22(16-23(30)27(33)34)31-24(17-28-29-31)19-10-4-1-5-11-19/h1-15,17,22-23,25H,16,18H2,(H,33,34)/t22-,23-/m0/s1 WRAIPUGPFSGITD-GOTSBHOMSA-N 318790 (2S,4S)-1-(2,2-diphenylacetyl)-4-(5-phenyl-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxylic acid::US10370388, Compound 100::US9624243, 100 Type-2 angiotensin II receptor Human 18.0 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318790&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681500 384222079 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819042 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)n1nncc1Cc1ccccc1 InChI=1S/C28H26N4O3/c33-27(26(21-12-6-2-7-13-21)22-14-8-3-9-15-22)31-19-24(17-25(31)28(34)35)32-23(18-29-30-32)16-20-10-4-1-5-11-20/h1-15,18,24-26H,16-17,19H2,(H,34,35)/t24-,25-/m0/s1 HBTISMUQTHYNOL-DQEYMECFSA-N 318791 (2S,4S)-4-(5-benzyl-1H-1,2,3-triazol-1-yl)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 101::US9624243, 101 Type-2 angiotensin II receptor Human 400 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318791&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677531 384222080 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819043 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1[C@@H](Cc2ccccc2)COCC1=O InChI=1S/C30H30N2O5/c33-27-20-37-19-25(16-21-10-4-1-5-11-21)32(27)24-17-26(30(35)36)31(18-24)29(34)28(22-12-6-2-7-13-22)23-14-8-3-9-15-23/h1-15,24-26,28H,16-20H2,(H,35,36)/t24-,25-,26-/m0/s1 OJWXNJCKTXACCI-GSDHBNRESA-N 318792 (2S,4S)-4-((S)-3-benzyl-5-oxomorpholino)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic ::US10370388, Compound 102::US9624243, 102 Type-2 angiotensin II receptor Human 499 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318792&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622464 384222081 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819044 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccc(F)cc1 InChI=1S/C28H28FNO4/c29-23-15-13-20(14-16-23)8-7-17-34-24-18-25(28(32)33)30(19-24)27(31)26(21-9-3-1-4-10-21)22-11-5-2-6-12-22/h1-6,9-16,24-26H,7-8,17-19H2,(H,32,33)/t24-,25-/m0/s1 GMJPSKAGKFLTFK-DQEYMECFSA-N 318793 (2S,4S)-1-(2,2-diphenylacetyl)-4-(3-(4-fluorophenyl)-propoxy)pyrrolidine-2-carboxylic acid::US10370388, Compound 104::US9624243, 104 Type-2 angiotensin II receptor Human 1316 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318793&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677514 384222082 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819045 COc1ccc(cc1C)C#CCN(C)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C31H32N2O4/c1-22-19-23(16-17-28(22)37-3)11-10-18-32(2)26-20-27(31(35)36)33(21-26)30(34)29(24-12-6-4-7-13-24)25-14-8-5-9-15-25/h4-9,12-17,19,26-27,29H,18,20-21H2,1-3H3,(H,35,36)/t26-,27-/m0/s1 ZLCKDXQPZWPTJX-SVBPBHIXSA-N 318794 (2S,4S)-1-(2,2-diphenylacetyl)-4-((3-(4-methoxy-3-methylphenyl)prop-2-yn-1-yl)(methyl)amino)pyrrolidine-2-carboxylic acid::US10370388, Compound 105::US9624243, 105 Type-2 angiotensin II receptor Human 2489 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318794&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622463 384222083 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819046 OC(=O)[C@@H]1C[C@H](CCCCc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C29H31NO3/c31-28(27(24-16-6-2-7-17-24)25-18-8-3-9-19-25)30-21-23(20-26(30)29(32)33)15-11-10-14-22-12-4-1-5-13-22/h1-9,12-13,16-19,23,26-27H,10-11,14-15,20-21H2,(H,32,33)/t23-,26-/m0/s1 AOXCIYMWJSEDFC-OZXSUGGESA-N 318795 (2S,4S)-1-(2,2-diphenylacetyl)-4-(4-phenylbutyl)-pyrrolidine-2-carboxylic acid::US10370388, Compound 106::US9624243, 106 Type-2 angiotensin II receptor Human 426 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318795&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681611 384222084 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819047 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)c1sccc1-c1ccccc1 InChI=1S/C29H25NO3S/c31-28(26(21-12-6-2-7-13-21)22-14-8-3-9-15-22)30-19-23(18-25(30)29(32)33)27-24(16-17-34-27)20-10-4-1-5-11-20/h1-17,23,25-26H,18-19H2,(H,32,33)/t23-,25-/m0/s1 LFNOXHBHIFQLEL-ZCYQVOJMSA-N 318796 (2S,4S)-1-(2,2-diphenylacetyl)-4-(3-phenylthiophen-2-yl)-pyrrolidine-2-carboxylic acid::US10370388, Compound 107::US9624243, 107 Type-2 angiotensin II receptor Human 461 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318796&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677817 384222085 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819048 OC[C@@H]1[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C27H29NO3/c29-20-24-25(31-18-10-13-21-11-4-1-5-12-21)19-28(24)27(30)26(22-14-6-2-7-15-22)23-16-8-3-9-17-23/h1-9,11-12,14-17,24-26,29H,10,13,18-20H2/t24-,25+/m1/s1 YFRCJLYBFGAYRN-RPBOFIJWSA-N 318797 1-((2R,3S)-2-(hydroxymethyl)-3-(3-phenylpropoxy)-azetidin-1-yl)-2,2-diphenylethanone::US10370388, Compound 108::US9624243, 108 Type-2 angiotensin II receptor Human 2054 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318797&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762289 384222086 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819049 OC[C@@H]1[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C27H29NO3/c29-20-24-25(31-18-10-13-21-11-4-1-5-12-21)19-28(24)27(30)26(22-14-6-2-7-15-22)23-16-8-3-9-17-23/h1-9,11-12,14-17,24-26,29H,10,13,18-20H2/t24-,25-/m1/s1 YFRCJLYBFGAYRN-JWQCQUIFSA-N 318798 (1-((2R,3R)-2-(hydroxymethyl)-3-(3-phenylpropoxy)-azetidin-1-yl)-2,2-diphenylethanone::US10370388, Compound 109::US9624243, 109 Type-2 angiotensin II receptor Human 650 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318798&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677667 384222087 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819050 CN(C)S(=O)(=O)NC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C30H35N3O5S/c1-32(2)39(36,37)31-29(34)27-21-26(38-20-12-15-23-13-6-3-7-14-23)22-33(27)30(35)28(24-16-8-4-9-17-24)25-18-10-5-11-19-25/h3-11,13-14,16-19,26-28H,12,15,20-22H2,1-2H3,(H,31,34)/t26-,27-/m0/s1 NPFUOBKNVTUWIO-SVBPBHIXSA-N 318759 (2S,4S)—N—(N,N-dimethylsulfamoyl)-1-(2,2-diphenylacetyl)-4-(3-phenylpropoxy)pyrrolidine-2-carboxamide::US10370388, Compound 112::US9624243, 50 Type-2 angiotensin II receptor Human 255 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318759&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762099 384222048 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819051 CN(C)S(=O)(=O)NC(=O)[C@H]1C[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N(C)CCCc1ccc(F)cc1 InChI=1S/C31H37FN4O4S/c1-34(2)41(39,40)33-30(37)28-21-27(35(3)20-10-11-23-16-18-26(32)19-17-23)22-36(28)31(38)29(24-12-6-4-7-13-24)25-14-8-5-9-15-25/h4-9,12-19,27-29H,10-11,20-22H2,1-3H3,(H,33,37)/t27-,28-/m1/s1 UDXHQRMQQJQHMN-VSGBNLITSA-N 410270 US10370388, Compound 114 Type-2 angiotensin II receptor Human 17.1 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410270&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 146676250 406791829 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819052 CN(C)S(=O)(=O)NC(=O)C1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N(C)CCCc1ccc(F)cc1 InChI=1S/C31H37FN4O4S/c1-34(2)41(39,40)33-30(37)28-21-27(35(3)20-10-11-23-16-18-26(32)19-17-23)22-36(28)31(38)29(24-12-6-4-7-13-24)25-14-8-5-9-15-25/h4-9,12-19,27-29H,10-11,20-22H2,1-3H3,(H,33,37)/t27-,28?/m0/s1 UDXHQRMQQJQHMN-MBMZGMDYSA-N 410271 US10370388, Compound 52 Type-2 angiotensin II receptor Human 63.2 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410271&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 146676251 406791830 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819053 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC2(C1)CCCON2Cc1ccccc1 InChI=1S/C33H37N3O4/c37-31(30(26-13-6-2-7-14-26)27-15-8-3-9-16-27)35-23-28(21-29(35)32(38)39)34-19-18-33(24-34)17-10-20-40-36(33)22-25-11-4-1-5-12-25/h1-9,11-16,28-30H,10,17-24H2,(H,38,39)/t28-,29-,33?/m0/s1 XWODPWDIMHTKNK-QXSWOPKKSA-N 318801 (2S,4S)-4-(6-benzyl-7-oxa-2,6-diazaspiro[4,5]decan-2-yl)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 115::US9624243, 115 Type-2 angiotensin II receptor Human 321 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318801&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762174 384222090 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819054 CN(CC#Cc1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C29H28N2O3/c1-30(19-11-14-22-12-5-2-6-13-22)25-20-26(29(33)34)31(21-25)28(32)27(23-15-7-3-8-16-23)24-17-9-4-10-18-24/h2-10,12-13,15-18,25-27H,19-21H2,1H3,(H,33,34)/t25-,26-/m0/s1 SPTDDEMGVGOBAE-UIOOFZCWSA-N 318802 (2S,4S)1-(2,2-diphenylacetyl)-4-(methyl(3-phenylprop-2-yn-1-yl)amino)pyrrolidine-2-carboxylic ::US10370388, Compound 116::US9624243, 116 Type-2 angiotensin II receptor Human 650 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318802&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622331 384222091 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819055 OC(=O)[C@@H]1C[C@H](CS(=O)(=O)Cc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C27H27NO5S/c29-26(25(22-12-6-2-7-13-22)23-14-8-3-9-15-23)28-17-21(16-24(28)27(30)31)19-34(32,33)18-20-10-4-1-5-11-20/h1-15,21,24-25H,16-19H2,(H,30,31)/t21-,24-/m0/s1 HJCIEOAWYBCWKI-URXFXBBRSA-N 318803 (2S,4S)-4-((benzylsulfonyl)methyl)-1-(diphenylacetyl)-pyrrolidine-2-carboxylic acid::US10370388, Compound 118::US9624243, 118 Type-2 angiotensin II receptor Human 314 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318803&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677488 384222092 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819056 OC(=O)[C@@H]1C[C@H](CS(=O)(=O)c2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C26H25NO5S/c28-25(24(20-10-4-1-5-11-20)21-12-6-2-7-13-21)27-17-19(16-23(27)26(29)30)18-33(31,32)22-14-8-3-9-15-22/h1-15,19,23-24H,16-18H2,(H,29,30)/t19-,23-/m0/s1 KTWUBWHZDMVDKG-CVDCTZTESA-N 318804 (2S,4S)-4-((phenylsulfonyl)methyl)-1-(diphenylacetyl)-pyrrolidine-2-carboxylic acid::US10370388, Compound 119::US9624243, 119 Type-2 angiotensin II receptor Human 2647 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318804&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681639 384222093 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819057 OC(=O)[C@H]1C[C@@H](CSCCc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C28H29NO3S/c30-27(26(23-12-6-2-7-13-23)24-14-8-3-9-15-24)29-19-22(18-25(29)28(31)32)20-33-17-16-21-10-4-1-5-11-21/h1-15,22,25-26H,16-20H2,(H,31,32)/t22-,25-/m1/s1 KQMAXUKNLKOSCK-RCZVLFRGSA-N 410276 US10370388, Compound 120 Type-2 angiotensin II receptor Human 1199 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410276&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 146676252 406791835 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819058 OC(=O)[C@@H]1C[C@H](CSCc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C27H27NO3S/c29-26(25(22-12-6-2-7-13-22)23-14-8-3-9-15-23)28-17-21(16-24(28)27(30)31)19-32-18-20-10-4-1-5-11-20/h1-15,21,24-25H,16-19H2,(H,30,31)/t21-,24-/m0/s1 CXXLZNHCGQJFBK-URXFXBBRSA-N 318806 (2S,4S)-4-((benzylthio)methyl)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 121::US9624243, 121 Type-2 angiotensin II receptor Human 57.7 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318806&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622327 384222095 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819059 OC(=O)[C@@H]1C[C@H](CSc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C26H25NO3S/c28-25(24(20-10-4-1-5-11-20)21-12-6-2-7-13-21)27-17-19(16-23(27)26(29)30)18-31-22-14-8-3-9-15-22/h1-15,19,23-24H,16-18H2,(H,29,30)/t19-,23-/m0/s1 FFTNAJKBQGJZOH-CVDCTZTESA-N 318807 (2S,4S)-1-(2,2-diphenylacetyl)-4-((phenylthio)methyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 122::US9624243, 122 Type-2 angiotensin II receptor Human 143 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318807&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622326 384222096 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819060 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)SCCCc1ccccc1 InChI=1S/C28H29NO3S/c30-27(26(22-14-6-2-7-15-22)23-16-8-3-9-17-23)29-20-24(19-25(29)28(31)32)33-18-10-13-21-11-4-1-5-12-21/h1-9,11-12,14-17,24-26H,10,13,18-20H2,(H,31,32)/t24-,25-/m0/s1 UAYMXVSZVUHHQJ-DQEYMECFSA-N 318808 (2S,4S)-1-(2,2-diphenylacetyl)-4-((3-phenylpropyl)thio)-pyrrolidine-2-carboxylic acid::US10370388, Compound 124::US9624243, 124 Type-2 angiotensin II receptor Human 363 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318808&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681558 384222097 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819061 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)S(=O)(=O)CCCc1ccccc1 InChI=1S/C28H29NO5S/c30-27(26(22-14-6-2-7-15-22)23-16-8-3-9-17-23)29-20-24(19-25(29)28(31)32)35(33,34)18-10-13-21-11-4-1-5-12-21/h1-9,11-12,14-17,24-26H,10,13,18-20H2,(H,31,32)/t24-,25-/m0/s1 SMQJHFDQORQADU-DQEYMECFSA-N 318809 (2S,4S)-1-(2,2-diphenylacetyl)-4-((3-phenylpropyl)-sulfonyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 125::US9624243, 125 Type-2 angiotensin II receptor Human 1244 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318809&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622330 384222098 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819062 CN(CCOc1ccccc1F)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C28H29FN2O4/c1-30(16-17-35-25-15-9-8-14-23(25)29)22-18-24(28(33)34)31(19-22)27(32)26(20-10-4-2-5-11-20)21-12-6-3-7-13-21/h2-15,22,24,26H,16-19H2,1H3,(H,33,34)/t22-,24-/m0/s1 XZGFVHNFFXJNTG-UPVQGACJSA-N 318810 (2S,4S)-1-(2,2-diphenylacetyl)-4-((2-fluorophenoxy)ethyl)(methyl)amino)pyrrolidine-2-carboxylic acid::US10370388, Compound 126::US9624243, 126 Type-2 angiotensin II receptor Human 20.5 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318810&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374623 384222099 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819063 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)SCCc1ccccc1 InChI=1S/C27H27NO3S/c29-26(25(21-12-6-2-7-13-21)22-14-8-3-9-15-22)28-19-23(18-24(28)27(30)31)32-17-16-20-10-4-1-5-11-20/h1-15,23-25H,16-19H2,(H,30,31)/t23-,24-/m0/s1 DBXYGTHVEKXVAM-ZEQRLZLVSA-N 318811 (2S,4S)-1-(2,2-diphenylacetyl)-4-(phenethylthio)pyrrolidine-2-carboxylic acid::US10370388, Compound 131::US9624243, 131 Type-2 angiotensin II receptor Human 652 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318811&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622193 384222100 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819064 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)SCCCc1ccc(F)cc1 InChI=1S/C28H28FNO3S/c29-23-15-13-20(14-16-23)8-7-17-34-24-18-25(28(32)33)30(19-24)27(31)26(21-9-3-1-4-10-21)22-11-5-2-6-12-22/h1-6,9-16,24-26H,7-8,17-19H2,(H,32,33)/t24-,25-/m0/s1 YANZCJOFCAZZGC-DQEYMECFSA-N 318812 (2S,4S)-1-(2,2-diphenylacetyl)-4((3-(4-fluorophenyl)propyl)thio)pyrrolidine-2-carboxylic acid::US10370388, Compound 133::US9624243, 133 Type-2 angiotensin II receptor Human 1738 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318812&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681513 384222101 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819065 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)S(=O)(=O)CCCc1ccc(F)cc1 InChI=1S/C28H28FNO5S/c29-23-15-13-20(14-16-23)8-7-17-36(34,35)24-18-25(28(32)33)30(19-24)27(31)26(21-9-3-1-4-10-21)22-11-5-2-6-12-22/h1-6,9-16,24-26H,7-8,17-19H2,(H,32,33)/t24-,25-/m0/s1 DGHBMICUFYBOQO-DQEYMECFSA-N 318813 (2S,4S)-1-(2,2-diphenylacetyl)-4((3-(4-fluorophenyl)propyl)sulfonyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 134::US9624243, 134 Type-2 angiotensin II receptor Human 954 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318813&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622194 384222102 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819066 CS(=O)(=O)NC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C29H32N2O5S/c1-37(34,35)30-28(32)26-20-25(36-19-11-14-22-12-5-2-6-13-22)21-31(26)29(33)27(23-15-7-3-8-16-23)24-17-9-4-10-18-24/h2-10,12-13,15-18,25-27H,11,14,19-21H2,1H3,(H,30,32)/t25-,26-/m0/s1 TXIUZQBNSNMVAH-UIOOFZCWSA-N 318814 (2S,4S)-1-(2,2-diphenylacetyl)-N-(methylsulfonyl)-4-(phenylpropoxy)pyrrolidine-2-carboxamide::US10370388, Compound 135::US9624243, 135 Type-2 angiotensin II receptor Human 240 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318814&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762409 384222103 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819067 CN(CCCc1ccc(F)cc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(N)=O InChI=1S/C29H32FN3O2/c1-32(18-8-9-21-14-16-24(30)17-15-21)25-19-26(28(31)34)33(20-25)29(35)27(22-10-4-2-5-11-22)23-12-6-3-7-13-23/h2-7,10-17,25-27H,8-9,18-20H2,1H3,(H2,31,34)/t25-,26-/m0/s1 KPZRZJUXBNKMTI-UIOOFZCWSA-N 318815 (2S,4S)-1-(2,2-diphenylacetyl)-44(3-(4-fluorophenyl)propyl)(methyl)amino)pyrrolidine-2-carboxamide::US10370388, Compound 136::US9624243, 136 Type-2 angiotensin II receptor Human 89.0 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318815&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622057 384222104 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819068 CN(CCCc1ccc(F)cc1)[C@H]1C[C@@H](C#N)N(C1)C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C29H30FN3O/c1-32(18-8-9-22-14-16-25(30)17-15-22)27-19-26(20-31)33(21-27)29(34)28(23-10-4-2-5-11-23)24-12-6-3-7-13-24/h2-7,10-17,26-28H,8-9,18-19,21H2,1H3/t26-,27-/m0/s1 CIYODQRQZJRWKS-SVBPBHIXSA-N 318816 (2S,4S)-1-(2,2diphenylacetyl)-4˜03-(4-fluorophenyl)propyl)(methyl)amino)pyrrolidine-2-carbonitrile::US10370388, Compound 137::US9624243, 137 Type-2 angiotensin II receptor Human 173 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318816&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622192 384222105 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819069 CN(CCCc1ccc(F)cc1)[C@H]1CC(N(C1)C(=O)C(c1ccccc1)c1ccccc1)c1nn[nH]n1 InChI=1S/C29H31FN6O/c1-35(18-8-9-21-14-16-24(30)17-15-21)25-19-26(28-31-33-34-32-28)36(20-25)29(37)27(22-10-4-2-5-11-22)23-12-6-3-7-13-23/h2-7,10-17,25-27H,8-9,18-20H2,1H3,(H,31,32,33,34)/t25-,26?/m0/s1 KNRLDBXQDSZTRX-PMCHYTPCSA-N 410289 US10370388, Compound 138 Type-2 angiotensin II receptor Human 3.52 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410289&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 146676255 406791846 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819070 OC(=O)[C@@H]1C=C(CN1C(=O)C(c1ccccc1)c1ccccc1)c1sccc1-c1ccccc1 InChI=1S/C29H23NO3S/c31-28(26(21-12-6-2-7-13-21)22-14-8-3-9-15-22)30-19-23(18-25(30)29(32)33)27-24(16-17-34-27)20-10-4-1-5-11-20/h1-18,25-26H,19H2,(H,32,33)/t25-/m0/s1 OERKEVDGARSKPT-VWLOTQADSA-N 318818 (S)-1-(2,2-diphenylacetyl)-4-(3-phenylthiophen-2-yl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid::US10370388, Compound 139::US9624243, 139 Type-2 angiotensin II receptor Human 2533 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318818&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681504 384222107 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819071 OC(=O)[C@@H]1C=C(CN1C(=O)C(c1ccccc1)c1ccccc1)C#CCCc1ccccc1 InChI=1S/C29H25NO3/c31-28(27(24-16-6-2-7-17-24)25-18-8-3-9-19-25)30-21-23(20-26(30)29(32)33)15-11-10-14-22-12-4-1-5-13-22/h1-9,12-13,16-20,26-27H,10,14,21H2,(H,32,33)/t26-/m0/s1 CNHMBDHFFFCFJM-SANMLTNESA-N 318819 (S)-1-(2,2-diphenylacetyl)-4-(4-phenylbut-1-yn-1-yl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid::US10370388, Compound 140::US9624243, 140 Type-2 angiotensin II receptor Human 674 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318819 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318819&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677697 384222108 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819072 OC(=O)[C@@H]1[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C27H27NO4/c29-26(24(21-14-6-2-7-15-21)22-16-8-3-9-17-22)28-19-23(25(28)27(30)31)32-18-10-13-20-11-4-1-5-12-20/h1-9,11-12,14-17,23-25H,10,13,18-19H2,(H,30,31)/t23-,25-/m0/s1 YVHCQCFELZHKAG-ZCYQVOJMSA-N 318820 (2S,3S)-1-(2,2-diphenylacetyl)-3-(3-phenylpropoxy)-azetidine-2-carboxylic acid::US10370388, Compound 142::US9624243, 142 Type-2 angiotensin II receptor Human 993 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318820&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677138 384222109 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819073 OC(=O)[C@H]1[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C27H27NO4/c29-26(24(21-14-6-2-7-15-21)22-16-8-3-9-17-22)28-19-23(25(28)27(30)31)32-18-10-13-20-11-4-1-5-12-20/h1-9,11-12,14-17,23-25H,10,13,18-19H2,(H,30,31)/t23-,25-/m1/s1 YVHCQCFELZHKAG-ILBGXUMGSA-N 318764 1-((2R,3S)-2-(hydroxymethyl)-3-(3-phenylpropoxy)-azetidin-1-yl)-2,2-diphenylethanone and 14(2S,3R)-2-(hydroxymethyl)-3-(3-phenylpropoxy)-azetidin-1-yl)-2,2-diphenylethanone::US10370388, Compound 143::US9624243, 56 Type-2 angiotensin II receptor Human 372 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318764&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677758 384222053 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819074 CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1 InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28) PSIFNNKUMBGKDQ-UHFFFAOYSA-N 318822 US10370388, Compound Losartin::US9624243, Losartin Type-2 angiotensin II receptor Human 11.0 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318822 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318822&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search LSN 7RL2,6VLT,5X23,5X24,5XXI 3961 384222111 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819075 CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1 InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28) PSIFNNKUMBGKDQ-UHFFFAOYSA-N 318822 US10370388, Compound Losartin::US9624243, Losartin Type-2 angiotensin II receptor Human 5.50 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318822 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318822&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search LSN 7RL2,6VLT,5X23,5X24,5XXI 3961 384222111 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819076 CC(C)C(NC(=O)C(CCCN=C(N)N)NC(=O)C(N)CC(N)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(C)C)C(=O)NC(Cc1cnc[nH]1)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(O)=O 410295 US10370388, Compound Angiotensin Type-2 angiotensin II receptor Human 1.80 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410295&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 5890 406791852 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 819077 CC(C)C(NC(=O)C(CCCN=C(N)N)NC(=O)C(N)CC(N)=O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(C)C)C(=O)NC(Cc1cnc[nH]1)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(O)=O 410295 US10370388, Compound Angiotensin Type-2 angiotensin II receptor Human 0.898 US Patent 10.7270/Q2K35X1F aid1803758 US10370388 McCarthy, TD; Naylor, A 8/6/2019 7/6/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=410295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=410295&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 5890 406791852 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7